Poly Medicure Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 — transcript filed; not yet summarisedQ4 FY26
Q4 FY26 earnings call
Poly Medicure reported FY26 standalone revenue of around Rs 1,662 crore, up about 4%, and consolidated revenue of Rs 1,875 crore, up 12.3%, with standalone EBITDA margin of 26.8%. Management described FY26 as a year of transition toward high-technology segments, including the acquisitions of PendraCare, Citieffe, and Medyneo in Brazil. The company guided FY27 consolidated revenue of Rs 2,300-2,400 crore and standalone revenue of Rs 1,900-1,950 crore, while flagging raw material cost pressure and Gulf-region shipping disruptions.